Institute of NeuroPhysiopathology (INP)
Created in 2018
Up & running (A)
Existing signals show a regular activitySocial networks
1,540 282Activities
Entity types
Location
27 Bd Jean Moulin, 13385 Marseille, France
Marseille
France
Employees
Scale: 51-200
Estimated: 151
Engaged catalyst
8
0 0Added in Motherbase
1 year, 3 months ago
Value proposition
The Institute of NeuroPhysiopathology (UMR7051) is a CNRS / AMU
training and research center studying brain disorders
The Institute of NeuroPhysiopathology (INP – UMR7051) was created on January 1st 2018 and is directed by François Devred. It is located in the Timone site of the Medical Faculty of Marseille and is supported by Aix-Marseille University (AMU) and the CNRS. The INP brings together 11 teams totalling 150 people, half of whom have permanent positions (statutory staff). The main objectives of the Institute are to study on a fundamental level, through animal and cell models (including reprogramming / iPS cell modelling), at different levels of integration (from molecular to animal models), and in various pathological contexts, the interactions between neuronal, glial, endothelial and immune cells, and their roles in the plasticity of neural networks, in biological clocks and in cognitive function. The teams of the Institute study during development and aging different conditions including Alzheimer's disease, multiple sclerosis, neuroinflammatory and neurodegenerative processes, glioblastoma, tumorigenesis, angiogenesis and alterations of the barrier blood brain (BBB).
The INP teams promote the development of diagnostic and therapeutic approaches, based in particular on the identification of biomarkers and therapeutic targets, on the development of new therapeutic molecules and on cell therapy strategies involving olfactory stem cells and iPS cells. The teams ambition valuation and partnership with the pharmaceutical industry, in particular through the creation of a "Joint Research Laboratory" with the biotechnology company VECT-HORUS. This partnership aims at developing new vectorisation strategies across the BBB into the CNS, and innovative therapeutic or imaging agents, that will benefit from such strategies to improve their brain delivery and efficacy.
molecular biology, chemistry, cell biology, integrated study of animal models, confocal imaging, super-resolution imaging, and TIRF imagingOriginal language
The Institute of NeuroPhysiopathology (UMR7051) is a CNRS / AMU
training and research center studying brain disorders
The Institute of NeuroPhysiopathology (INP – UMR7051) was created on January 1st 2018 and is directed by François Devred. It is located in the Timone site of the Medical Faculty of Marseille and is supported by Aix-Marseille University (AMU) and the CNRS. The INP brings together 11 teams totalling 150 people, half of whom have permanent positions (statutory staff). The main objectives of the Institute are to study on a fundamental level, through animal and cell models (including reprogramming / iPS cell modelling), at different levels of integration (from molecular to animal models), and in various pathological contexts, the interactions between neuronal, glial, endothelial and immune cells, and their roles in the plasticity of neural networks, in biological clocks and in cognitive function. The teams of the Institute study during development and aging different conditions including Alzheimer's disease, multiple sclerosis, neuroinflammatory and neurodegenerative processes, glioblastoma, tumorigenesis, angiogenesis and alterations of the barrier blood brain (BBB).
The INP teams promote the development of diagnostic and therapeutic approaches, based in particular on the identification of biomarkers and therapeutic targets, on the development of new therapeutic molecules and on cell therapy strategies involving olfactory stem cells and iPS cells. The teams ambition valuation and partnership with the pharmaceutical industry, in particular through the creation of a "Joint Research Laboratory" with the biotechnology company VECT-HORUS. This partnership aims at developing new vectorisation strategies across the BBB into the CNS, and innovative therapeutic or imaging agents, that will benefit from such strategies to improve their brain delivery and efficacy.
Accueil | Institute of NeuroPhysiopathology
https://inp.univ-amu.fr/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Carnot STAR | Other 8 Nov 2022 | | |
 Ministère chargé de l'Enseignement supérieur et de la Recherche Government Administration | Ministère chargé de l'Enseignement supérieur et de la Recherche Government Administration | Other 31 Dec 2024 | | |
 CMA CGM Transportation, Logistics, Supply Chain and Storage | CMA CGM Transportation, Logistics, Supply Chain and Storage | Other 31 Dec 2024 | | |
 Région Sud - Provence-Alpes-Côte d'Azur National and local authorities, Government Administration | Région Sud - Provence-Alpes-Côte d'Azur National and local authorities, Government Administration | Other 11 May 2024 | | |
 Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 8 Apr 2024 | | |
 Société des Neurosciences NGO, Think Tank, Civic and Social Organizations | Société des Neurosciences NGO, Think Tank, Civic and Social Organizations | Other 7 Mar 2024 | | |
 CNRS Research, Research Services | CNRS Research, Research Services | Other 25 Mar 2025 | | |
 SATT Sud-Est Research, National and local authorities, Research Services | SATT Sud-Est Research, National and local authorities, Research Services | Other 8 Mar 2024 | | |